Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
Daiichi Sankyo
Dow
Argus Health
Baxter
Harvard Business School
Chubb
UBS
AstraZeneca

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040331

« Back to Dashboard

NDA 040331 describes MEPERIDINE HYDROCHLORIDE, which is a drug marketed by Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Barr, Duramed Pharms Barr, Epic Pharma, Mikart, Specgx Llc, Sun Pharm Inds Inc, Sun Pharm Industries, Vintage Pharms, Wyeth Ayerst, Hospira, and Icu Medical Inc, and is included in forty-two NDAs. It is available from nine suppliers. Additional details are available on the MEPERIDINE HYDROCHLORIDE profile page.

The generic ingredient in MEPERIDINE HYDROCHLORIDE is meperidine hydrochloride. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
Summary for 040331
Tradename:MEPERIDINE HYDROCHLORIDE
Applicant:Epic Pharma
Ingredient:meperidine hydrochloride
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Pharmacology for NDA: 040331
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 040331
Suppliers and Packaging for NDA: 040331
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040331 ANDA Epic Pharma, LLC 42806-050 N 42806-050-01
MEPERIDINE HYDROCHLORIDE meperidine hydrochloride TABLET;ORAL 040331 ANDA Epic Pharma, LLC 42806-051 N 42806-051-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:May 28, 1999TE:AARLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:May 28, 1999TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
Argus Health
Fuji
Fish and Richardson
Queensland Health
Harvard Business School
Johnson and Johnson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot